DeepMed Research

Academisch Ziekenhuis Maastricht

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1986-01-01

Employees: 5K

Market Cap: -

Website: http://www.mumc.nl

Clinical Trials

Effects of VitamIN K2 and D3 supplementaTion on PET/MRI in Carotid Artery Disease

Not Applicable

Not yet recruiting

Conditions: Carotid Artery Disease
Coronary Artery Disease

Interventions: Other: Placebo
Dietary Supplement: MK-7 and vitamin D3

First Posted Date: 2019-07-08

Last Posted Date: 2023-09-21

Lead Sponsor: Academisch Ziekenhuis Maastricht

Target Recruit Count: 52

Registration Number: NCT04010578

fMRI-study in Patients With Small Fiber Neuropathy

Conditions: Small Fiber Neuropathy

Interventions: Diagnostic Test: functional MRI

First Posted Date: 2019-03-26

Last Posted Date: 2022-07-26

Lead Sponsor: Academisch Ziekenhuis Maastricht

Target Recruit Count: 60

Registration Number: NCT03889080

Locations: 🇳🇱
Maastricht University Medical Center, Maastricht, Netherlands

Pharmacokinetic Boosting of Osimertinib

Early Phase 1

Completed

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Cobicistat

First Posted Date: 2019-02-28

Last Posted Date: 2022-09-26

Lead Sponsor: Academisch Ziekenhuis Maastricht

Target Recruit Count: 11

Registration Number: NCT03858491

Locations: 🇳🇱
Maastricht University Medical Centre, Maastricht, Limburg, Netherlands
🇳🇱
Antoni van Leeuwenhoek hospital, Amsterdam, Noord-Holland, Netherlands

The Effect of Arginine on Classic Galactosemia

Phase 2

Completed

Conditions: Classic Galactosemia

Interventions: Drug: Arginine Aspartate

First Posted Date: 2018-07-09

Last Posted Date: 2018-09-27

Lead Sponsor: Academisch Ziekenhuis Maastricht

Target Recruit Count: 4

Registration Number: NCT03580122

Locations: 🇳🇱
Academisch Ziekenhuis Maastricht, Maastricht, Limburg, Netherlands

Southeast Netherlands Advanced Metastatic Breast Cancer Registry

Recruiting

Conditions: Advanced Breast Cancer
Metastatic Breast Cancer

First Posted Date: 2018-07-05

Last Posted Date: 2024-07-23

Lead Sponsor: Academisch Ziekenhuis Maastricht

Target Recruit Count: 7000

Registration Number: NCT03577197

Locations: 🇳🇱
Multiple hospitals in the Netherlands (see Eligibility), Maastricht, Netherlands

Light Intensity Physical Activity Trial

Not Applicable

Completed

Conditions: Light Intensity Physical Activity
Aortic Stiffness
Pulse Wave Velocity
Diabetes Mellitus
Type2 Diabetes
Artery Disease
Physical Activity
Physical Exercise
Arterial Stiffness
Sedentary Lifestyle

Interventions: Behavioral: Workshops control group LiPAT
Behavioral: Interactive workshops LiPAT intervention group
Device: Wrist-worn feedback physical activity monitor
Device: Smartphone application LiPAT
Behavioral: Telephone Coaching

First Posted Date: 2018-01-30

Last Posted Date: 2023-02-02

Lead Sponsor: Academisch Ziekenhuis Maastricht

Target Recruit Count: 132

Registration Number: NCT03415880

Locations: 🇳🇱
Maastricht University, Maastricht, Netherlands

Reappraisal of Atrial Fibrillation: RACE-V - Work Package 5

Conditions: Atrial Fibrillation

Interventions: Device: Implantable loop recorder

First Posted Date: 2017-04-24

Last Posted Date: 2018-07-19

Lead Sponsor: Academisch Ziekenhuis Maastricht

Target Recruit Count: 380

Registration Number: NCT03124576

Locations: 🇳🇱
AZMaastricht, Maastricht, Limburg, Netherlands

Spinal Cord Stimulation in Small Fibre Neuropathy

Not Applicable

Terminated

Conditions: Small Fiber Neuropathy

Interventions: Device: Spinal cord stimulation

First Posted Date: 2016-09-19

Last Posted Date: 2019-03-25

Lead Sponsor: Academisch Ziekenhuis Maastricht

Target Recruit Count: 1

Registration Number: NCT02905396

Locations: 🇳🇱
Maastricht University Medical Center, Maastricht, Netherlands

Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy

Phase 2

Completed

Conditions: Small Fiber Neuropathy

Interventions: Drug: Intravenous Immunoglobulin
Drug: Placebo

First Posted Date: 2015-12-22

Last Posted Date: 2019-07-05

Lead Sponsor: Academisch Ziekenhuis Maastricht

Target Recruit Count: 60

Registration Number: NCT02637700

Locations: 🇳🇱
Maastricht University Medical Center, Maastricht, Netherlands

Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy

Phase 3

Completed

Conditions: Small Fiber Neuropathy

Interventions: Drug: Placebo
Drug: Lacosamide

First Posted Date: 2013-07-30

Last Posted Date: 2018-01-10

Lead Sponsor: Academisch Ziekenhuis Maastricht

Target Recruit Count: 25

Registration Number: NCT01911975

Locations: 🇳🇱
Maastricht University Medical Center, Maastricht, Netherlands

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy